3-(2-Chloroacetyl)-1-[(thiophen-2-yl)methyl]urea, 97%, 100mg

1,2-BIS((2R,5R)-2,5-DIPHENYLPHOSPHOLAN-1-YL)ETHANE, 95%, 50mg

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

6-Bromo-3-hydroxyisoquinoline, 98.0%, 5g

4-Chloro-2-nitro-1-(trifluoromethoxy)benzene, 95.0%, 25g

N-Benzyltetrahydro-2H-pyran-4-amine, 95.0%, 5g

4-(6-CHLOROPYRIDIN-3-YL)TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID, 95.0%, 100mg

N-Amino-2-(4-methoxyphenoxy)ethanamide, 95.0%, 5g

2-NITROANILINE HYDROCHLORIDE, 95%, 25g

1-(5-Pyrimidinyl)ethanone, 95.0%, 1g

HO-PEG17-OH, 100mg

1-(4-Methyl-pyridin-2-yl)-1H-pyrrole-2-carbaldehyde, 95.0%, 250mg

2-(2-methylphenyl)ethanimidamide hydrochloride, 95.0%, 10g